Search company, investor...

Informed Medical Communications

informedmedical.com

Stage

Other Investors | Alive

About Informed Medical Communications

Informed Medical is an interactive medical information services provider that enables biopharmaceutical companies to market directly to physicians and patients.

Headquarters Location

160 Mercer Street

New York, New York, 10012,

United States

Missing: Informed Medical Communications's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Informed Medical Communications's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Informed Medical Communications Patents

Informed Medical Communications has filed 3 patents.

The 3 most popular patent topics include:

  • Mobile phones
  • Network protocols
  • Optical character recognition
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/8/2018

7/7/2020

Optical character recognition, Wireless networking, Mobile phones, Social networking services, Network protocols

Grant

Application Date

10/8/2018

Grant Date

7/7/2020

Title

Related Topics

Optical character recognition, Wireless networking, Mobile phones, Social networking services, Network protocols

Status

Grant

Latest Informed Medical Communications News

Informed Medical Merges with IC Axon

Mar 16, 2011

Informed Medical Merges with IC Axon March 16, 2011 Private equity-backed Informed Medical Communications – a provider of peer-to-peer medical forums, training services and integrated medical communications for the biopharmaceutical industry – has merged with healthcare training company IC Axon. Financial terms of the deal were not released. Montreal-based IC Axon was advised by Fairmount Partners. PRESS RELEASE Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums, training services, and integrated medical communications for the biopharmaceutical industry, and IC Axon, an industry-recognized leader in the design and development of training programs for the healthcare industry, today announced the merger of the two organizations. The combined enterprise will offer a full suite of sales and leadership training, Key Opinion Leader skills development, and medical communications services for the domestic and global biopharmaceutical/medical device industries. This includes medical content development, workshop design and execution, as well as multichannel pull-through programs with highly interactive peer meetings. Steven K. Budd, IMC’s CEO commented, “This merger will create a formidable training company that offers the full continuum of services from multimedia curricula design and content development to elite skills training anchored in our proven model for influencing customers through dialogue. In addition, IMC’s medical communications capabilities will be significantly enhanced by the addition of IC Axon’s team and their expertise in developing customized, engaging medical content.” With growing challenges facing bio-pharmaceutical organizations, IMC and IC Axon executives believe the combined capabilities will provide their healthcare company customers with more comprehensive training and marketing solutions that improve business outcomes and efficiency of spend. Carole Gins, General Manager IC Axon / Dialogue Training and newly appointed President of IMC summarizes, “We are excited by the merger with IMC, as we believe IMC’s unique DialogueTraining(SM) framework for enhancing sales and promotional impact and their team of expert trainers and workshop facilitators provides the perfect complement to IC Axon’s core competency in the design, development, and production of high-impact training programs. We are confident that our respective clients will benefit from the combined training and medical communications capabilities of IC Axon and Informed Medical Communications. ” IMC and IC Axon will continue to operate out of their current locations in Edison, NJ and Montreal, QC, respectively. IC Axon was advised by Fairmount Partners, a specialty investment bank based outside of Philadelphia, and IMC was advised by Excel Partners, based in New York City. About Informed Medical Communications Informed Medical Communications (www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting peer-to-peer medical programs and delivering integrated medical communications. Additionally, IMC’s major businesses are enhanced by DialogueTraining, a communications training service for elite skill development for sales organizations and speaker bureaus. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company. About IC Axon IC Axon (www.icaxon.com) is a recognized leader in the healthcare training industry, specializing in the design and development of clinically focused training programs for domestic and global pharmaceutical, bio-pharma, and medical device clients. IC Axon offers a wide range of custom education programs and formats tailored to the business and training needs of sales representatives, sales leadership, marketing, and medical teams. Over the past 16 years, IC Axon has reinforced its core competencies in instructional design consulting, medical/clinical content development, medical illustration/graphics creation, technology innovation, and professional project management. Based in Montreal, IC Axon continues to provide innovative and medically valid foundational, launch, and advanced training programs for many of the top pharmaceutical companies in the US and globally. © 2015 Buyouts Insider / Argosy Group LLC

Informed Medical Communications Frequently Asked Questions (FAQ)

  • Where is Informed Medical Communications's headquarters?

    Informed Medical Communications's headquarters is located at 160 Mercer Street, New York.

  • What is Informed Medical Communications's latest funding round?

    Informed Medical Communications's latest funding round is Other Investors.

  • Who are the investors of Informed Medical Communications?

    Investors of Informed Medical Communications include De Novo Ventures.

  • Who are Informed Medical Communications's competitors?

    Competitors of Informed Medical Communications include Oligomerix, CMC Biologics, Irvine Pharmaceutical Services, Trophos, ReSearch Pharmaceutical Services and 12 more.

Compare Informed Medical Communications to Competitors

L
Laureate Pharma

Laureate Pharma, Inc. is a full service contract manufacturing organization(CMO) providing development and cGMP manufacturing services in the company's FDA registered facilities in Princeton, New Jersey. The company is dedicated to supporting the development and commercialization of biopharmaceutical, drug and diagnostic products for pharmaceutical, diagnostic and biotech companies.The company aims to provide a range of product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The company's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply.The company view the company's customers as partners and provide them with flexible solutions that reduce time to clinic and market. Focused on operational excellence, the company's highly experienced staff works with the company's customers to improve the quality of their products and processes.The company value the company's customers, stakeholders and associates. Therefore, the company measure the company's success by meeting the company's customers' needs, generating results in terms of quality, timeliness and on budget performance, as well as fostering an environment of trust, growth and diversity for the company's team.

K
Kryosphere

Kryosphere provides customized biorepository, logistical, and clinical sample management services to companies with a critical biospecimen component. Kryosphere delivers secure, scalable solutions to customers ranging from small, emerging entities to large corporations worldwide.

Plexus Ventures Logo
Plexus Ventures

The company provide business development services to clients in the pharmaceutical, biotechnology, consumer health, and drug delivery industries worldwide. The company's team members represent an array of nationalities and a mix of commercial, manufacturing, medical, and scientific expertise, gained from decades of experience with both global pharmaceutical and development-stage companies

A
Angel Biotechnology

Angel Biotechnology Holdings PLC (AIM: ABH) is a world class, contract biomanufacturing company offering process development services and pre-GMP and cGMP manufacturing to support biotechnology and pharmaceutical companies worldwide. Angel's principal activity is the manufacture and supply of materials for use in early stage drug development and pre-clinical studies, along with drug product and CMC documentation for Phases I, II and III clinical trials and the manufacture of licensed drugs or vaccines. nnAngel is managed by a team that has more than 100 years' combined experience in pharmaceutical and biopharmaceutical manufacture, gained in companies such as Glaxo and Serologicals Inc. nnAngel operates out of Pentlands Science Park, near Edinburgh.

A
Adjuvant Research Services

Adjuvant Research Services is a provider of nationwide clinical development temporary staffing for the biopharmaceutical industry. The company's consultants are supplied to the company's biopharmaceutical customers for regional monitoring, in-house monitoring, auditing, medical writing (including manuscript and protocol writing), project management, medical monitoring and pharmacovigilence services).

E
Emiliem

Emiliem operates as a biopharmaceutical company that is engaged in early oncology R&D. The company develops Molecular Targeted Therapeutics (MTTs) for oncology and other indications. MTTs are therapeutic agents that target biologically important processes central to the development and progression of cancer and other diseases. The company's clinical development strategy is focused on identifying patients most likely to respond to treatment and monitoring clinical outcome with specific biomarkers used as diagnostic assays.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.